Authors


Ben Casavant, PhD

Latest:

Using a Blood Collection Device to Advance Genetic Research in Parkinson Disease: James Beck, PhD & Ben Casavant, PhD

The chief scientific officer of the Parkinson’s Foundation and chief executive officer of Tasso discussed their company partnership to expand and accelerate genetic research in Parkinson Disease. [WATCH TIME: 6 minutes]


Walter E. Kaufmann, MD

Latest:

Transformation of Rett Syndrome Research With the Emergence of Adult Data: Walter E. Kaufmann, MD

The adjunct professor of human genetics at Emory University School of Medicine discussed previous research on Rett syndrome that initially provided crucial insight on the neuromuscular condition in adult populations. [WATCH TIME: 2 minutes]


Kristin Galetta, MD, MSEd

Latest:

Understanding Differences in B-Cell Depleting Medications for MS: Kristin Galetta, MD, MSEd

The professor of neurology at Brigham and Women’s Hospital discussed her presentation on B-cell depleting therapies such as ocrelizumab and ofatumumab for the treatment of multiple sclerosis. [WATCH TIME: 2 minutes]


Emma Waldon, RN

Latest:

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.


Tomas Kalincik, MD, PhD

Latest:

Capabilities of Stem Cell Transplantation vs Other Relapsing MS Therapies: Tomas Kalincik, MD, PhD

The professor of neurology and biostatistician at University of Melbourne and Royal Melbourne Hospital spoke on stem cell transplantation in patients with MS and its effectiveness in comparison with other traditional approaches. [WATCH TIME: 2 minutes]


Dan Volz

Latest:

The Partnership Between MT2020+ and Medtronic: Dileep Yavagal, MD, and Dan Volz

The professor of clinical neurology at University of Miami and MT2020+ chair, and president of Medtronic's Neurovascular Business discussed the effort to improve global accessibility of mechanical thrombectomy.


Richard Gershon, PhD

Latest:

Mass Screening for Cognitive Changes: Richard Gershon, PhD

The vice chair for research at the Northwestern University Feinberg School of Medicine discussed the potential of the mobile toolbox battery to screen hundreds of thousands for cognitive impairment.


Andreas V. Alexopoulos, MD, MPH

Latest:

The Current State and Future Promise of Magnetoencephalography (MEG) in Epilepsy and Beyond

Magnetoencephalography provides an opportunity for physicians to capture a more dynamic view of brain function over time and space that may offer an advantage to clinical care.


Jessica Zwerling, MD, MS

Latest:

Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.


Rohit Das, MD

Latest:

AUPN Leadership Minute Episode 36: Faculty Retention

Episode 36 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and David G. Standaert, MD, PhD, of the University of Alabama at Birmingham. [WATCH TIME: 4 minutes]


David S. Knopman, MD

Latest:

The Aducanumab Saga and the Future of Antiamyloid Monoclonal Antibodies

The journey of aducanumab (Aduhelm; Biogen) from development to the FDA is a tortured one, but its path may serve to teach the Alzheimer disease field valuable lessons as it strives forward to develop disease-modifying therapies.


Barry Singer, MD

Latest:

Appropriate Steps Needed for Integration of Biosimilars in MS Treatment Paradigm: Barry Singer, MD

The director and founder of The MS Center for Innovations in Care provided thoughts on the potential role of biosimilars in treating multiple sclerosis and the steps needed to ensure that this integration process is safe. [WATCH TIME: 4 minutes]


Atom Sarkar, MD, PhD

Latest:

Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation

Surgical care for PD is safe and effective, and should no longer be treated as a consideration of last resort, but as a treatment option discussed early in the disease course with the patient and their family.


Valerie J. Block, PT, DPTSc

Latest:

Innovative Wearables to Tackle Bladder Dysfunction in Multiple Sclerosis: Valerie J. Block, PT, DPTSc

The assistant professor of neurology at UCSF Weill Institute for Neurosciences talked about a study that explored the use of commercial wearable devices to monitor and manage bladder dysfunction in multiple sclerosis. [WATCH TIME: 6 minutes]


Veronica Hood, PhD

Latest:

Vaccination and Seizure Risk in Dravet Syndrome: Veronica Hood, PhD, MS

The scientific director at the Dravet Syndrome Foundation commented on the concern associated with vaccination in this patient population, noting that investigators have not observed an exacerbated risk profile with the COVID-19 vaccines. [WATCH TIME: 2 minutes]


Jason M. Schwalb, MD

Latest:

A Team Approach to Asleep Deep Brain Stimulation

Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.


Omar Al-Louzi, MD

Latest:

Balancing Efficacy and Safety With MS Disease-Modifying Therapies: Omar Al-Louzi, MD

The director of the Visual Outcomes Laboratory at Cedars Sinai talked about the current treatments used in MS and the risks associated with them at 2023 ACTRIMS Forum. [WATCH TIME: 3 minutes]


Chris Kalafatis, MD, MRCPsych

Latest:

Patient and Clinician Takeaways on the CognICA: Chris Kalafatis, MD, MRCPsych

The chief medical officer of Cognetivity Neurosciences outlined the benefits a new integrated assessment has for clinicians and patients with dementias and multiple sclerosis. [WATCH TIME: 4 minutes]


Anvi Gadani, MD

Latest:

Advanced Therapeutic Options for Parkinson Disease and Essential Tremor: Anvi Gadani, MD

The assistant clinical professor of medicine at Medstar Georgetown University Hospital talked about her presentation where she covered various advanced therapies for managing Parkinson disease and essential tremor. [WATCH TIME: 5 minutes]


Charlyn Gomez, BS

Latest:

Achieving Greater Diversity in Dementia Research: A Call to Action

Achieving greater diversity in study populations is a focus of increasing scrutiny, priority, and funding in all medical research, including studies enrolling individuals on the continuum of prodromal Alzheimer disease, mild cognitive impairment, and Alzheimer disease.


Lara V. Marcuse, MD

Latest:

Empowering Women to Develop Leadership Skills in Neurology: Lara V. Marcuse, MD

The codirector of the Mount Sinai Epilepsy Program at the Icahn School of Medicine at Mount Sinai talked about the Women in Neurology and Leadership session she spoke in at IFN 2023. [WATCH TIME: 3 minutes]


Daniel Bandari, MD, MS

Latest:

Key Points for the Management of Multiple Sclerosis

Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, provide key takeaways for the treatment of patients with multiple sclerosis.


Justin Moy

Latest:

A Patient Perspective on Gene Therapy for Neuromuscular Diseases: Justin Moy

The second-year PhD student in bioinformatics at Boston University who lives with LAMA2 congenital muscular dystrophy talked about the potential impact and challenges of gene therapy in neuromuscular diseases. [WATCH TIME: 5 minutes]


Rajiv Jain, PhD

Latest:

Exploring New Therapies for MS With Research on T-bet+ memory B Cells: Rajiv Jain, PhD

At the 2023 ACTRIMS, the post-doctoral associate in the department of clinical neurosciences at the University of Calgary, spoke on the impact of researching T-Bet+ memory B cells for new therapies in multiple sclerosis. [WATCH TIME: 5 minutes]


Alise Carlson, MD

Latest:

Implications of Diagnosing and Misdiagnosing Multiple Sclerosis

Alise Carlson, MD, resident of Cleveland Clinic, details the factors and long-term effects misdiagnosing a patient with multiple sclerosis can have on their quality of life.


Andrew C. Charles, MD

Latest:

Future Directions for the Management of Migraine

Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.


Latisha Sharma, MD

Latest:

AUPN 2022 Spring Chairs Session: Simulations for Training in Neurology

David G. Standaert, MD, PhD; Wolfgang Muhlhofer, MD; and Latisha Sharma, MD, share their experience in applying simulation-based learning in Neurology and will discuss the current state and future potential of this approach. [WATCH TIME: 1 hour, 25 minutes]


Nikita Chhabra, DO

Latest:

Exploring the Risk of Hypertension Following Erenumab Treatment for Migraine: Nikita Chhabra, DO

The neurology PGY-3 at Mayo Clinic in Arizona talked about findings from a retrospective cohort study that examined blood pressure in patients who were prescribed a migraine medication. [WATCH TIME: 6 minutes]


Jiya Desai

Latest:

The Impact of a Social Media–Based Educational Intervention to Promote Training in Social Determinants of Health Among Medical Residents

Social determinants of health are conditions that people are born into and live under that affect their health, and can greatly impact clinical outcomes as well as contribute to health disparities and inequalities.


Claudene J. George, MD

Latest:

Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.

© 2024 MJH Life Sciences

All rights reserved.